Sun Sep 15 12:00:47 UTC 2024: ## Mysterious Paralysis Syndrome That Affected Children Seems to Have Disappeared
**Denver, Colorado** – A syndrome that paralyzed children across the nation, known as acute flaccid myelitis (AFM), appears to have vanished as mysteriously as it arrived. While the cause remains elusive, scientists are working diligently to understand the phenomenon and develop treatments.
AFM was first identified in 2014, with sporadic cases dating back to 2009. The syndrome caused unexplained muscle weakness and limb paralysis in children, prompting concern among healthcare professionals. Cases surged in 2016 and 2018, but plummeted in 2020, possibly due to COVID-19 mitigation measures. While the suspected culprit, enterovirus D68 (EV-D68), returned in 2022, the expected surge in paralysis cases did not occur.
The CDC recorded only 18 confirmed AFM cases in 2023, a stark contrast to the 238 cases in 2018. While the link between EV-D68 and AFM has strengthened, researchers are still grappling with the reasons for the syndrome’s sudden disappearance.
Dr. Kevin Messacar, an infectious disease specialist at Children’s Hospital Colorado, suggests that the virus itself may have changed, or children’s immune systems might be responding differently. Other environmental factors may also play a role.
Lydia Pilarowski, a 16-year-old from Denver, was diagnosed with AFM in 2014, becoming one of the first known cases. While she has learned to adapt to her disability, the journey has been challenging.
“The process of learning how to live with the after-effects of AFM never really ends,” said her mother, Dr. Sarah Lacey, a pediatrician.
Researchers continue to investigate potential causes, including the emergence of a different EV-D68 variant, and whether the syndrome was always present but misdiagnosed. Another theory suggests that widespread EV-D68 exposure during the pandemic may have built immunity, reducing susceptibility.
While AFM is no longer an immediate public health crisis, scientists are working to better understand the syndrome and develop treatments. A research lab at the University of Colorado Anschutz Medical Campus is comparing EV-D68 samples that cause paralysis with those that don’t, hoping to identify key differences.
Dr. Carlos Pardo, a professor of neurology at John Hopkins University, emphasizes that AFM is not a simple, singular entity.
“It could be that doctors simply didn’t pick up that a virus might be the root cause,” he said, explaining that other syndromes share similar symptoms.
Despite the uncertainty surrounding AFM, researchers have made significant progress since 2014. An antibody-based treatment for EV-D68 is currently in trials, and several vaccine candidates are approaching human testing.
While the mystery of AFM continues, Lydia Pilarowski remains hopeful that researchers will uncover the cause, both for her understanding and to prevent future occurrences. She acknowledges the uncertainty she faces and stresses the importance of embracing the unknown.
First Piper 